{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:15:56Z","timestamp":1779203756417,"version":"3.51.4"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006464","name":"Birla Institute of Technology and Science, Pilani","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ejphar.2024.176664","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T23:37:53Z","timestamp":1716507473000},"page":"176664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Natriuretic peptide system in hypertension: Current understandings of its regulation, targeted therapies and future challenges"],"prefix":"10.1016","volume":"976","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3291-0450","authenticated-orcid":false,"given":"Vishwadeep","family":"Shelke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Dagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhupendra","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4627-5504","authenticated-orcid":false,"given":"Anil Bhanudas","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176664_bib1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/HYPERTENSIONAHA.121.17041","article-title":"Selective inhibition of the C-domain of ACE (angiotensin-converting enzyme) combined with inhibition of NEP (Neprilysin): a potential new therapy for hypertension","volume":"78","author":"Alves-Lopes","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176664_bib2","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI67383","article-title":"Atrial natriuretic peptide is negatively regulated by microRNA-425","volume":"123","author":"Arora","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2024.176664_bib3","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1210\/clinem\/dgaa643","article-title":"The renal Extraction and the natriuretic action of GLP-1 in humans depend on interaction with the GLP-1 receptor","volume":"106","author":"Asmar","year":"2021","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2024.176664_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.lfs.2018.08.031","article-title":"C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis","volume":"209","author":"Bae","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2024.176664_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004872-199207000-00002","article-title":"Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension","volume":"10","author":"Bevan","year":"1992","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2024.176664_bib6","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2337\/db16-1318","article-title":"Neprilysin is required for angiotensin-(1\u20137)\u2019s Ability to enhance insulin secretion via its proteolytic activity to generate angiotensin-(1\u20132)","volume":"66","author":"Brar","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2024.176664_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/VHRM.S11816","article-title":"Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination","author":"Cagnoni","year":"2010","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejphar.2024.176664_bib8","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1210\/me.2003-0125","article-title":"Chronic cardiac-specific Thyrotoxicosis increases myocardial \u03b2-adrenergic Responsiveness","volume":"18","author":"Carvalho-Bianco","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2024.176664_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00271-19","article-title":"Functional Screening Identifies MicroRNA regulators of Corin activity and atrial natriuretic peptide Biogenesis","volume":"39","author":"Celik","year":"2019","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2024.176664_bib10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.lfs.2013.10.020","article-title":"Stimulation of ANP by angiotensin-(1-9) via the angiotensin type 2 receptor","volume":"93","author":"Cha","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2024.176664_bib11","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/HYPERTENSIONAHA.121.17159","article-title":"First-in-human study of MANP: a novel ANP (atrial natriuretic peptide) analog in human hypertension","volume":"78","author":"Chen","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176664_bib12","doi-asserted-by":"crossref","DOI":"10.5334\/gh.1116","article-title":"Serum atrial natriuretic peptide, NPPA promoter methylation, and cardiovascular disease: a 10-year follow-up study in Chinese adults","volume":"17","author":"Chen","year":"2022","journal-title":"Global Heart"},{"key":"10.1016\/j.ejphar.2024.176664_bib13","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/S2666-7568(23)00129-0","article-title":"Impact of hypertension prevalence trend on mortality and burdens of dementia and disability in England and Wales to 2060: a simulation modelling study","volume":"4","author":"Chen","year":"2023","journal-title":"The Lancet Healthy Longevity"},{"key":"10.1016\/j.ejphar.2024.176664_bib14","doi-asserted-by":"crossref","first-page":"R669","DOI":"10.1152\/ajpregu.00354.2019","article-title":"Long-term blood pressure lowering and cGMP-activating actions of the novel ANP analog MANP","volume":"318","author":"Chen","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ehf2.12319","article-title":"Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure","volume":"5","author":"Chirinos","year":"2018","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.ejphar.2024.176664_bib16","article-title":"Treatment of pulmonary hypertension with angiotensin II receptor blocker and neprilysin inhibitor sacubitril\/valsartan","volume":"12","author":"Clements","year":"2019","journal-title":"Circulation: Heart Fail."},{"key":"10.1016\/j.ejphar.2024.176664_bib17","series-title":"Omapatrilat-the Story of Overture and Octave","first-page":"1","author":"Coats","year":"2002"},{"key":"10.1016\/j.ejphar.2024.176664_bib18","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/hc4001.097191","article-title":"Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease?","volume":"104","author":"Corti","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176664_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2119\/molmed.2015.00047","article-title":"Triiodothyronine attenuates prostate cancer progression mediated by \u03b2-adrenergic stimulation","volume":"22","author":"Delgado-Gonz\u00e1lez","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejphar.2024.176664_bib20","doi-asserted-by":"crossref","first-page":"F1489","DOI":"10.1152\/ajprenal.00668.2013","article-title":"Natriuretic peptides buffer renin-dependent hypertension","volume":"306","author":"Demerath","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib21","doi-asserted-by":"crossref","first-page":"19196","DOI":"10.1074\/jbc.M109.010777","article-title":"A familial mutation renders atrial natriuretic Peptide resistant to proteolytic degradation","volume":"284","author":"Dickey","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176664_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-019-0304-z","article-title":"Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure","volume":"20","author":"Dizaye","year":"2019","journal-title":"BMC Pharmacology and Toxicology"},{"key":"10.1016\/j.ejphar.2024.176664_bib23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/HYPERTENSIONAHA.122.20836","article-title":"Ovariectomy via 12\/15-lipoxygenase augments angiotensin II-induced hypertension and its pathogenesis in female mice","volume":"80","author":"Dutta","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176664_bib24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.121.18837","article-title":"MANP (M-atrial natriuretic peptide) reduces blood pressure and furosemide-induced increase in aldosterone in hypertension","volume":"79","author":"Dzhoyashvili","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176664_bib25","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.CIR.97.23.2323","article-title":"Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo","volume":"97","author":"Ferro","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176664_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.108.125088","article-title":"Endothelin-stimulated human B-type natriuretic peptide gene expression is mediated by Yin Yang 1 in association with histone deacetylase 2","volume":"53","author":"Glenn","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176664_bib27","series-title":"Histone Modifications in Therapy","first-page":"337","article-title":"Chapter 13 - histone modification as a potential preventative and therapeutic approach for cardiovascular disease","author":"Habibian","year":"2020"},{"key":"10.1016\/j.ejphar.2024.176664_bib28","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14723","article-title":"The effect of neprilysin and renin inhibition on the renal dysfunction following ischemia\u2010reperfusion injury in the rat","volume":"9","author":"Hammad","year":"2021","journal-title":"Physiological Reports"},{"key":"10.1016\/j.ejphar.2024.176664_bib29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.122.19794","article-title":"MicroRNA-195a-5p regulates blood pressure by inhibiting NKCC2A","volume":"80","author":"Hao","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176664_bib30","doi-asserted-by":"crossref","first-page":"H276","DOI":"10.1152\/ajpheart.00029.2022","article-title":"\u03b2-Blockers are associated with increased B-type natriuretic peptide levels differently in men and women in heart failure with preserved ejection fraction","volume":"323","author":"Harada","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib31","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1006\/jmcc.1999.1030","article-title":"Effect of interleukin-1\u03b2 on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture","volume":"31","author":"Harada","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/HYPERTENSIONAHA.115.05610","article-title":"B-type natriuretic peptide deletion leads to progressive hypertension, associated organ damage, and reduced survival","volume":"66","author":"Holditch","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176664_bib33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/pharmaceutics12040320","article-title":"Dual angiotensin receptor and neprilysin inhibitor ameliorates portal hypertension in portal hypertensive rats","volume":"12","author":"Hsu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2024.176664_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1290253","article-title":"Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176664_bib35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3892\/etm.2023.12073","article-title":"Glucocorticoids ameliorate cardiorenal syndrome through the NPR1\/SGK1 pathway in natriuretic peptide receptor A-heterozygous mice","volume":"26","author":"Huang","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2024.176664_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148682","article-title":"Effects of elevation of ANP and its deficiency on cardiorenal function","volume":"7","author":"Ilatovskaya","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2024.176664_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jch.14154","article-title":"Association of thyroid hormones with blood pressure and arterial stiffness in the general population: the Dali study","volume":"23","author":"Jamal","year":"2021","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.ejphar.2024.176664_bib38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jch.14152","article-title":"Thyroid hormones regulate both cardiovascular and renal mechanisms underlying hypertension","volume":"23","author":"Jankauskas","year":"2021","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.ejphar.2024.176664_bib39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41440-020-0408-2","article-title":"Long noncoding RNAs as novel players in the pathogenesis of hypertension","volume":"43","author":"Jiang","year":"2020","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2024.176664_bib40","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.HYP.28.5.847","article-title":"Differential expression and autoradiographic localization of atrial natriuretic peptide receptor in spontaneously hypertensive and normotensive rat testes: diminution of testosterone in hypertension","volume":"28","author":"Kapasi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176664_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227728","article-title":"Associations between high blood pressure and DNA methylation","volume":"15","author":"Kazmi","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176664_bib42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm.3128","article-title":"GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure","volume":"19","author":"Kim","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2024.176664_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12931-016-0335-6","article-title":"C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice","volume":"17","author":"Kimura","year":"2016","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2024.176664_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/life11090986","article-title":"The causal relationship between endothelin-1 and hypertension: focusing on endothelial dysfunction, arterial stiffness, vascular remodeling, and blood pressure regulation","author":"Kostov","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.ejphar.2024.176664_bib45","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1074\/jbc.M113.511444","article-title":"Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase\/natriuretic peptide receptor-A gene: INTERACTIVE roles of modified histones, histone acetyltransferase, p300, and Sp1","volume":"289","author":"Kumar","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176664_bib46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2011.03.042","article-title":"Influence of sex and hormone status on circulating natriuretic peptides","volume":"58","author":"Lam","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15698\/cst2019.01.170","article-title":"Serum-and glucocorticoid-inducible kinase 1 and the response to cell stress","volume":"3","author":"Lang","year":"2019","journal-title":"Cell Stress"},{"key":"10.1016\/j.ejphar.2024.176664_bib48","first-page":"477","article-title":"Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats","volume":"20","author":"Lee","year":"2016","journal-title":"kjpp"},{"key":"10.1016\/j.ejphar.2024.176664_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13148-020-00927-0","article-title":"Association between NPPA promoter methylation and hypertension: results from Gusu cohort and replication in an independent sample","volume":"12","author":"Li","year":"2020","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ejphar.2024.176664_bib50","article-title":"Hypermethylation of brain natriuretic peptide gene is associated with the risk of rheumatic heart disease","volume":"37","author":"Li","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejphar.2024.176664_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170150","article-title":"Endogenous ET-1 promotes ANP secretion through activation of COX2-L\u2013PGDS\u2013PPAR\u03b3 signaling in hypoxic beating rat atria","volume":"122","author":"Li","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2024.176664_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113017","article-title":"MicroRNA-122\u20135p promotes renal fibrosis and injury in spontaneously hypertensive rats by targeting FOXO3","volume":"411","author":"Liu","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2024.176664_bib53","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ndt\/gfac232","article-title":"miRNA-23a modulates sodium-hydrogen exchanger 1 expression: studies in medullary thick ascending limb of salt-induced hypertensive rats","volume":"38","author":"Lombari","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2024.176664_bib54","article-title":"Evidence for angiotensin II as a naturally existing suppressor for the guanylyl cyclase A receptor and cyclic GMP generation","author":"Ma","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176664_bib55","article-title":"MANP in hypertension with metabolic syndrome: proof-of-concept study of natriuretic peptide-based therapy for cardiometabolic disease","author":"Ma","year":"2023","journal-title":"JACC (J. Am. Coll. Cardiol.): Basic to Translational Science"},{"key":"10.1016\/j.ejphar.2024.176664_bib56","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/cvr\/cvy226","article-title":"Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy","volume":"115","author":"Malek","year":"2019","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.ejphar.2024.176664_bib57","unstructured":"Malek, V., Sharma, N., Gaikwad, A.B., Histone Acetylation Regulates Natriuretic Peptides and Neprilysin Gene Expressions in Diabetic Cardiomyopathy and Nephropathy."},{"key":"10.1016\/j.ejphar.2024.176664_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1874467212666181122092300","article-title":"Histone acetylation regulates natriuretic peptides and neprilysin gene expressions in diabetic cardiomyopathy and nephropathy","volume":"12","author":"Malek","year":"2019","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176664_bib59","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.pharep.2019.05.008","article-title":"Simultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathy","volume":"71","author":"Malek","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2024.176664_bib60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.lfs.2019.02.027","article-title":"Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy","volume":"221","author":"Malek","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2024.176664_bib61","doi-asserted-by":"crossref","first-page":"R624","DOI":"10.1152\/ajpregu.00324.2010","article-title":"Angiotensin II-stimulated secretion of arginine vasopressin is inhibited by atrial natriuretic peptide in humans","volume":"300","author":"Matsukawa","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib62","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jacc.2009.04.080","article-title":"A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions","volume":"54","author":"McKie","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/159349","article-title":"TNF-Alpha regulates natriuretic peptides and aquaporins in human bronchial epithelial cells BEAS-2B","volume":"2013","author":"Mezzasoma","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2024.176664_bib64","article-title":"ANP and BNP exert anti-inflammatory action via NPR-1\/cGMP Axis by interfering with canonical, non-canonical, and alternative routes of inflammasome activation in human THP1 cells","author":"Mezzasoma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176664_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/biolre\/ioy179","article-title":"Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats","volume":"100","author":"Mishra","year":"2019","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ejphar.2024.176664_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41371-023-00851-9","article-title":"Comparison of the effects of angiotensin receptor\u2013neprilysin inhibitors and thiazide diuretic\/renin\u2013angiotensin system inhibitor combination therapy in hypertensive patients: a retrospective cohort study","author":"Mitsuno","year":"2023","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ejphar.2024.176664_bib67","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5301\/jn.5000008","article-title":"Aliskiren: the first direct renin inhibitor available for clinical use","volume":"24","author":"Morganti","year":"2011","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ejphar.2024.176664_bib68","doi-asserted-by":"crossref","first-page":"L1172","DOI":"10.1152\/ajplung.00087.2004","article-title":"C-type natriuretic peptide attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"287","author":"Murakami","year":"2004","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biology11071017","article-title":"Roles of natriuretic peptides and the significance of neprilysin in cardiovascular diseases","author":"Nakagawa","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.ejphar.2024.176664_bib70","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.peptides.2018.05.012","article-title":"Atrial and brain natriuretic peptides: hormones secreted from the heart","volume":"111","author":"Nakagawa","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2024.176664_bib71","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/dom.14135","article-title":"The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes","volume":"22","author":"Nielsen","year":"2020","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejphar.2024.176664_bib72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00004872-199203000-00011","article-title":"Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension","volume":"10","author":"O'Connell","year":"1992","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2024.176664_bib73","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025931","article-title":"Salt intake causes B-type natriuretic peptide elevation independently of blood pressure elevation in the general population without hypertension and heart disease","volume":"100","author":"Ohashi","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.ejphar.2024.176664_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1223733","article-title":"ACE2 overexpression in corticotropin-releasing-hormone cells offers protection against pulmonary hypertension","volume":"17","author":"Oliveira","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176664_bib75","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1210\/endo.140.11.7121","article-title":"Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse Models1","volume":"140","author":"Pandey","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2024.176664_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcha.2021.100821","article-title":"Effects and clinical implications of sacubitril\/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: a 24-month follow-up","volume":"35","author":"Paolini","year":"2021","journal-title":"IJC Heart & Vasculature"},{"key":"10.1016\/j.ejphar.2024.176664_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.991112","article-title":"C-type natriuretic peptide preserves central neurological function by maintaining blood-brain barrier integrity","volume":"15","author":"Perez-Ternero","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176664_bib78","first-page":"568","article-title":"C-type natriuretic peptide in essential hypertension: old ways for a new time","volume":"8","author":"Perunovic","year":"2023","journal-title":"JACC (J. Am. Coll. Cardiol.): Basic to Translational Science"},{"key":"10.1016\/j.ejphar.2024.176664_bib79","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/cvr\/cvab240","article-title":"Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology","volume":"118","author":"Petraina","year":"2022","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.ejphar.2024.176664_bib80","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbadis.2006.11.004","article-title":"Endothelin-1 and angiotensin II contribute to BNP but not c-fos gene expression response to elevated load in isolated mice hearts","volume":"1772","author":"Piuhola","year":"2007","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2024.176664_bib81","doi-asserted-by":"crossref","first-page":"R770","DOI":"10.1152\/ajpregu.00435.2017","article-title":"Angiotensin AT1A receptors expressed in vasopressin-producing cells of the supraoptic nucleus contribute to osmotic control of vasopressin","volume":"314","author":"Sandgren","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2017.05.054","article-title":"Attenuated diuresis and natriuresis in response to glucagon-like peptide-1 in hypertensive rats are associated with lower expression of the glucagon-like peptide-1 receptor in the renal vasculature","volume":"811","author":"Savignano","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176664_bib83","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/febs.13701","article-title":"Transforming growth factor \u03b21 antagonizes the transcription, expression and vascular signaling of guanylyl cyclase\/natriuretic peptide receptor A \u2013 role of \u03b4EF1","volume":"283","author":"Sen","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2024.176664_bib84","article-title":"New drugs and therapies in pulmonary arterial hypertension","author":"Shah","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176664_bib85","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015708","article-title":"Angiotensin receptor\u2010neprilysin inhibition attenuates right ventricular remodeling in pulmonary hypertension","volume":"9","author":"Sharifi Kia","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2024.176664_bib86","doi-asserted-by":"crossref","first-page":"E664","DOI":"10.1210\/jc.2012-3855","article-title":"Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men","volume":"98","author":"Skov","year":"2013","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2024.176664_bib87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EC-13-0087","article-title":"Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males","volume":"3","author":"Skov","year":"2014","journal-title":"Endocrine Connections"},{"key":"10.1016\/j.ejphar.2024.176664_bib88","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/hy0302.105214","article-title":"Posttranscriptional control of BNP gene expression in angiotensin II\u2013induced hypertension","volume":"39","author":"Suo","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176664_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01454-5","article-title":"Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure","volume":"11","author":"Takahashi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.176664_bib90","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/147323000403200109","article-title":"Interleukin-6-Induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes","volume":"32","author":"Tanaka","year":"2004","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejphar.2024.176664_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235845","article-title":"The expression of BNP, ET-1, and TGF-\u03b21 in myocardium of rats with ventricular arrhythmias","author":"Tian","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176664_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196697","article-title":"MicroRNA-425 and microRNA-155 cooperatively regulate atrial natriuretic peptide expression and cGMP production","volume":"13","author":"Vandenwijngaert","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176664_bib93","first-page":"15","volume":"vol. 18","author":"Vargas-Uricoechea","year":"2014"},{"key":"10.1016\/j.ejphar.2024.176664_bib94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2008.11.146","article-title":"The relationship between tumor necrosis factor-\u03b1, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure","volume":"141","author":"Vaz P\u00e9rez","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib95","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1038\/s41598-024-55724-z","article-title":"The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function","volume":"14","author":"Wajdlich","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.176664_bib96","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017499","article-title":"Associations of B\u2010type natriuretic peptide and its coding gene promoter methylation with functional outcome of acute ischemic stroke: a mediation analysis","volume":"9","author":"Wang","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2024.176664_bib97","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1038\/s41598-018-25489-3","article-title":"MicroRNA-143 modulates the expression of Natriuretic Peptide Receptor 3 in cardiac cells","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.176664_bib98","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s00134-003-1910-0","article-title":"Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction","volume":"29","author":"Witthaut","year":"2003","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejphar.2024.176664_bib99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yjmcc.2015.02.019","article-title":"Natriuretic peptide receptor 3 (NPR3) is regulated by microRNA-100","volume":"82","author":"Wong","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176664_bib100","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/MCB.01114-15","article-title":"Novel MicroRNA regulators of atrial natriuretic peptide production","volume":"36","author":"Wu","year":"2016","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2024.176664_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115968","article-title":"Protective effect of novel angiotensin receptor neprilysin inhibitor S086 on target organ injury in spontaneously hypertensive rats","volume":"170","author":"Xiao","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"55","key":"10.1016\/j.ejphar.2024.176664_bib102","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21811","article-title":"Low fT3 is associated with diminished health-related quality of life in patients with acute coronary syndrome treated with drug-eluting stent: a longitudinal observational study","volume":"8","author":"Xue","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2024.176664_bib103","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/01677063.2022.2028784","article-title":"lncRNA XIST induces A\u03b2 accumulation and neuroinflammation by the epigenetic repression of NEP in Alzheimer's disease","volume":"36","author":"Yan","year":"2022","journal-title":"J. Neurogenet."},{"key":"10.1016\/j.ejphar.2024.176664_bib104","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1210\/jc.2018-01437","article-title":"Sex hormones and change in N-terminal pro\u2013B-type natriuretic peptide levels: the multi-ethnic study of atherosclerosis","volume":"103","author":"Ying","year":"2018","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2024.176664_bib105","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/ATVBAHA.115.305230","article-title":"Histone methyltransferase SET1 mediates angiotensin II\u2013induced endothelin-1 transcription and cardiac hypertrophy in mice","volume":"35","author":"Yu","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2024.176664_bib106","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.peptides.2016.09.009","article-title":"Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor","volume":"86","author":"Yu","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2024.176664_bib107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.122.19637","article-title":"Attenuated relationships between indexes of volume overload and atrial natriuretic peptide in uncontrolled, sustained volume-dependent primary hypertension","volume":"80","author":"Yusuf","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.176664_bib108","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.bbrc.2018.07.023","article-title":"Recombinant human brain natriuretic peptide regulates PI3K\/AKT\/mTOR pathway through lncRNA EGOT to attenuate hypoxia-induced injury in H9c2 cardiomyocytes","volume":"503","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2024.176664_bib109","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.3892\/mmr.2015.4247","article-title":"Increased B-type-natriuretic peptide promotes myocardial cell apoptosis via the B-type-natriuretic peptide\/long non-coding RNA LSINCT5\/caspase-1\/interleukin 1\u03b2 signaling pathway","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2024.176664_bib110","article-title":"Selective HDAC8 inhibition attenuates isoproterenol-induced cardiac hypertrophy and fibrosis via p38 MAPK pathway","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176664_bib111","article-title":"Arcuate angiotensin II increases arterial pressure via coordinated increases in sympathetic nerve activity and vasopressin secretion","volume":"9","author":"Zhigang","year":"2022","journal-title":"eneuro"},{"key":"10.1016\/j.ejphar.2024.176664_bib112","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/aps.2018.30","article-title":"miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges","volume":"39","author":"Zhou","year":"2018","journal-title":"Acta Pharmacol. Sin."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924003522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924003522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T03:08:07Z","timestamp":1719630487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924003522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":112,"alternative-id":["S0014299924003522"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176664","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natriuretic peptide system in hypertension: Current understandings of its regulation, targeted therapies and future challenges","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"176664"}}